Apotex Health Corp. (TSX:APTX)
Canada · Delayed Price · Currency is CAD 31.87
-0.50 (-1.54%)
At close: Aug 28, 2026
Apotex Health Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Apotex Health stock has a consensus rating of "Buy" and an average price target of $41.34. The average 1-year stock price forecast is 29.71% higher than the current stock price, while the lowest is $40.00 (+25.51%) and the highest is $44.30 (+39.00%).
Price Target: $41.34 (+29.71%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Apotex Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| CIBC | CIBC | Buy Maintains $40.00 | Buy | Maintains | $40.00 | +25.51% | Aug 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $42.00 | Buy | Maintains | $42.00 | +31.79% | Aug 13, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $40.00 | Buy | Maintains | $40.00 | +25.51% | Aug 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $43.00 | Buy | Maintains | $43.00 | +34.92% | Aug 13, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $39.00 → $43.00 | Buy | Reiterates | $39.00 → $43.00 | +34.92% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
3.40B
from 3.49B
Decreased by -2.70%
Revenue Next Year
3.69B
from 3.40B
Increased by 8.53%
EPS This Year
2.18
EPS Next Year
2.36
from 2.18
Increased by 8.20%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.